SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WHL who wrote (2461)5/10/1998 2:47:00 PM
From: Angel Medina  Read Replies (1) of 3725
 

If the past is any indication of the future, IMAT's prospects seem very bleak for a rather long time to come. With limited working capital, IMAT has taken on board a moribund company ( although a good idea in principle) at a time when resources could be used for revenue generating purposes.

Unlike some of you in the thread, I feel that the Scan Centers will play a much more important role in IMAT's future than apparent at this juncture. More capital should be deployed to that endeavor. It is big demand at the Scan Centers that will generate sales of Scan machines, not the other way around.

Sadly, if Imatron performs as poorly with their new markets as they did with the markets they DID control before 4/1/98, we are in for more agony.

For a person so bullish on Imatron's technogy, I lament having to say these things, but the picture is clear for us to see. That is if you've been around for three and a half years as I have.

Nevertheless, still long and patient on IMAT. I clearly recall that I used have the same good feeling about MCIC's potential in early 1976 when the stock was 7/8 of a point, and some said that AT&T would crush them.

Again, HANG IN THERE.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext